At a glance
- Originator Merck & Co
- Class Antibacterials; Beta-lactams
- Mechanism of Action Leucocyte elastase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
Most Recent Events
- 30 Jun 1997 No-Development-Reported for Emphysema in USA (PO)
- 29 Nov 1995 New profile
- 29 Nov 1995 Preclinical development for Emphysema in USA (Unknown route)